Results 151 to 160 of about 6,310,447 (337)
Tempest WiFi network is going away [PDF]
The \u27tempest\u27 wireless network will be retired on January 1 ...
UMS Information Technology Services
core +1 more source
(No. 43) -- Veal Calves and Factory Farming [PDF]
, 1978 Veal calves and factory farming Is T-61 a humane substitute for Sodium pentobarbital?
Humane Information Services, Inc.
core +1 more source
Understanding the Pathway of Cancer Information Seeking: Cancer Information Services as a Supplement to Information from Other Sources. [PDF]
J Cancer Educ, 2023 Reifegerste D +6 more
europepmc +1 more source
In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Natural killer (NK) cells might contribute to motor neuron death in amyotrophic lateral sclerosis (ALS) through direct cytotoxicity, a process that could be inhibited with the FDA‐approved JAK/STAT pathway inhibitor, tofacitinib. This study aimed to verify that tofacitinib can suppress NK cell cytotoxicity, investigate if immune cell
Benjamin J. Murdock +8 more
wiley +1 more source
(No. 08) -- Laboratory Legislation [PDF]
, 1969 Laboratory Legislation A Bill Our Officers\u27 ...
Humane Information Services, Inc.
core +1 more source
Humanidades Médicas, 2010 Se presentan los resultados de una investigación de innovación tecnológica desarrollada entre marzo y septiembre de 2009, en la Dirección Provincial de Salud de Camagüey.
Antonio Obed Tarajano Roselló +2 more
doaj
[Digital personalized health information services from physicians: survey results of patients' and physicians' acceptance and expectations]. [PDF]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2023 Link E, Memenga P.
europepmc +1 more source
Information Gathering Methods in Immigration and Naturalization Service Proceedings [PDF]
, 1975 D. Scott Aberson
openalex +1 more source
Real‐World Comparison of High‐Efficacy Versus Non‐High‐Efficacy Therapies in Multiple Sclerosis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective The choice of the first disease modifying treatment (DMT) in multiple sclerosis (MS) is a topic of great interest, and whether high‐efficacy DMTs should be the first choice remains debated. We compared treatment outcomes (no evidence of disease activity [NEDA] and its components) between treatment‐naïve relapsing–remitting MS (RRMS ...
Sarmad Al‐Araji +9 more
wiley +1 more source